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Abstract
Background: Human adenoviruses of species B, C, and E (HAdV-B, –C, -E) are frequent causative agents of acute
respiratory infections worldwide. As part of a surveillance program aimed at identifying the etiology of influenza-like
illness (ILI) in Egypt, we characterized 105 adenovirus isolates from clinical samples collected between 2003 and
2010.
Methods: Identification of the isolates as HAdV was accomplished by an immunofluorescence assay (IFA) and
confirmed by a set of species and type specific polymerase chain reactions (PCR).
Results: Of the 105 isolates, 42% were identified as belonging to HAdV-B, 60% as HAdV–C, and 1% as HAdV-E.
We identified a total of six co-infections by PCR, of which five were HAdV-B/HAdV-C co-infections, and one was a
co-infection of two HAdV-C types: HAdV-5/HAdV-6. Molecular typing by PCR enabled the identification of eight
genotypes of human adenoviruses; HAdV-3 (n = 22), HAdV-7 (n = 14), HAdV-11 (n = 8), HAdV-1 (n = 22), HAdV-2 (20),
HAdV-5 (n = 15), HAdV-6 (n = 3) and HAdV-4 (n = 1). The most abundant species in the characterized collection of
isolates was HAdV-C, which is concordant with existing data for worldwide epidemiology of HAdV respiratory
infections.
Conclusions: We identified three species, HAdV-B, -C and -E, among patients with ILI over the course of 7 years in
Egypt, with at least eight diverse types circulating.
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Background
Human adenoviruses (HAdV) belong to the family Ade-
noviridae and the genus Mastadenovirus. Seven HAdV
species are formally recognized by the International Com-
mittee on Taxonomy of Viruses, indicated by letters A-G
and encompassing the 54 accepted HAdV types, desig-
nated by numbers 1 through 54. The clinical manifesta-
tions of HAdV infection varies with the species and type
of virus, ranging from asymptomatic infection to mild re-
spiratory (HAdV-B1, HAdV-C, HAdV-E), gastrointestinal
(HAdV-F), and ocular (HAdV-B, HAdV-D, HAdV-E)
disease. Life threatening pneumonia, septicemia and endo-
carditis are also possible in immunecompromised indi-
viduals or those with an underlying a comorbidity [1-5].
Among HAdV-associated acute respiratory disease, the
majority of infections are caused by three species: HAdV-B,
HAdV-C, and HAdV-E [6]. Approximately 60% of HAdV
infections in children and young adults are caused by
HAdV-C [7-11], and asymptomatic carriers of HAdV-C
are frequently detected due to the ability of this species to
establish persistent infections [7,12,13]. HAdV-B (HAdV-
3, -7, -11, -14, -16, and −21) and HAdV-E (HAdV-4) are
most commonly associated with outbreaks of acute fe-
brile respiratory illness, conjunctivitis, and pneumonia in
crowded populations [14-17]. Co-infections with multiple
types, either from the same species or different species, have
been shown to occur frequently in immunocompromised
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patients [18,19] and have been documented in other sus-
ceptible populations [20,21].
Compared to other regions of the globe, relatively few
studies have examined the contribution of HAdV to the
burden of respiratory, ocular, or enteric disease in Egypt
[6,22-26]. Only one study was conducted in Egypt to deter-
mine the most prevalent species and types of HAdV-
associated influenza-like illness (ILI) [6]. In the current
study, we used a molecular typing approach to characterize
HAdV species and types associated with ILI from eight
sites across Egypt from 2003–2010.
Methods
Sample collection
Adenovirus isolates (n = 105) examined in this study
were derived from oropharyngeal (OP) swabs (n = 99)
obtained from patients that presented to one of eight
surveillance sites from 2003–2010 (Figure 1). All sam-
ples were obtained from pediatric and adult patients that
met the World Health Organization (WHO) ILI surveil-
lance case definition (fever >38°C and respiratory mani-
festations of cough, sore throat or coryza with onset of
illness within the previous 3 days) and were enrolled.
OP swabs were obtained along with basic demographic
information. OP swabs were placed in viral transport
medium (VTM) and transported to NAMRU-3 in Cairo,
Egypt, where they were stored at −70°C until further
processing.
Ethical approval
Ethical approval was obtained from the institutional re-
view board (IRB) of the US Naval Medical Research Unit
No. 3 (NAMRU-3), protocol DOD#NAMRU3.2004.0023
(N3 169), in compliance with all applicable federal regula-
tions governing the protection of human subjects. Written
informed consent was waived by the IRB, and samples
contained no patient identifiers or links to clinical data.
The protocol, including the exemption of written in-
formed consent, received signatory approval from the
Egyptian Ministry of Health and Population prior to IRB
approval.
Virus isolation
Clinical specimens were treated with 10 μl of each of the
following antibiotics: penicillin (100,000U/ml)/streptomycin
(100,000 μg/ml), gentamicin (50 mg/ml)) and amphotericin
B (2.50 μg/ml) as an anti-fungal agent, for ten minutes.









Figure 1 Map displaying locations of 8 surveillance sites through Egypt, grouped by region – Alexandria (blue), Delta Region (purple),
Greater Cairo (green), and Upper Egypt (orange). The number of isolates by species and type for each region is displayed in Table 1.
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MDCK (ATCC# CCL-34), NCI-H292 (ATCC# CRL-1848)
and LLC-MK2 (ATCC# CCL-7.1) to maximize recovery of
respiratory viral pathogens. Cell cultures were examined for
cytopathic effect (CPE) for 12–14 days post-inoculation.
One hundred and five HAdV isolates were recovered.
HAdV identification was determined by indirect immuno-
flourescence antibody (IFA) test (Respiratory Viral Screen
IFA Kit, LIGHT DIAGNOSTICS™, Millipore, MA, USA).
After confirmation, infected tissue culture fluid (ITCF)
was collected and stored at −70°C until further processing.
DNA extraction
DNA was extracted from 200 μl of ITCF using MagNA
Pure LC Total Nucleic Acid Isolation Kit (Roche). Ex-
tracted DNA was stored at −20°C for further analysis.
Control strains for adenovirus
The prototype strains of HAdV were obtained from
American Type Culture Collection (ATCC): HAdV-1
(VR-1), -2 (VR-846), -3 (VR-3), -4 (VR-1572), -5 (VR-5),
-6 (VR-6), -7 (VR-7), -11 (VR-12), -14 (VR-15), and −21
(VR-256) to be used as controls.
Molecular identification of adenovirus species and
genotype
Primers used for adenovirus identification and species de-
termination were obtained from the literature. For PCR
confirmation of HAdV IFA positives, we used the univer-
sal primers designed by Xu et al. [27] and followed their
protocol and cycling conditions with the exception of
using a 25 μl reaction instead of the 50 μl used in the
paper. Determination of viral species was accomplished by
a minor modification of the BCE Multiplex [28] by utiliz-
ing the HadV-B reaction as a monoplex and maintaining a
duplex reaction for HAdV-C and HAdV-E. This multiplex
is able to discriminate between HAdV4a-like and HAdV-
4p-like based on a 30 bp insertion/deletion mutation in
the E1A gene, as described previously [11]. For further
PCR-based typing of HAdV-B positive samples, multiplex
PCR for HAdV-3, 7 and 21 [29] was performed, and any
negative samples were then tested with specific assays for
HAdV-11, 14, 16, and 35, as previously described [6]. Typ-
ing of the HAdV-C species was performed by a multiplex
PCR targeting the fiber gene [30]. All PCR reactions were
performed as described in their respective publications.
All products were run on a 2% agarose gel at 100 V with
ethidium bromide and were visualized and recorded by
photography on a UV light box.
Data analysis
Data were analyzed using SAS software, version 9, of the
SAS System for Windows (SAS Institute Inc). Chi-square
goodness of fit test was used to assess significance of bi-
variate associations. When expected values did not meet
the frequency assumptions required for this test, Fisher’s
exact test was used. Associations were considered signifi-
cant by a p-value less than 0.05.
Results
In this study, we sought to characterize adenovirus isolates
with the aim of identifying the most prevalent species and
types circulating in Egypt in recent years. OP swabs from
patients with ILI were collected during the period 2003–
2010. The samples were tested for the presence of a viral
etiology by inoculation onto cell monolayer and the ob-
served for CPE. Samples showing CPE were then screened
for HAdV by an immunofluorescence assay and confirmed
with our PCR testing algorithm. A total of 105 HAdV iso-
lates were identified among the 99 HAdV-positive sam-
ples; 44 (42%) were HAdV-B, 60 (57%) were HAdV-C, and
1 (1%) was HAdV-E (Table 1, Figure 2). Co-infections were
detected in 6 (6%) of the 99 specimens, 5 (5%) with
HAdV-B and HAdV-C and 1 (1%) with two different types
of HAdV-C. Molecular typing of HAdV-B species (Figure 2)
identified the following types: HAdV-3 (n = 22), HAdV-
7 (n = 14), and HAdV-11 (n = 8) (p = 0.03). Among the
HAdV-C isolates, we identified significantly more HAdV-
1 (n = 22) and HAdV-2 (n = 20) than HAdV-5 (n = 15) and
HAdV-6 (n = 3) (p < 0.01). One sample in this group con-
tained a coinfection of HAdV-5/HAdV-6. The five HAdV-
B/HAdV-C coinfections included HAdV-3/HAdV-1 (n = 3),
HAdV-3/HAdV-2 (n = 1), and HAdV-3/HAdV-5 (n = 1).
The only HAdV-E isolate was typed as a HAdV-4a-like
genomic variant.
Distribution of HAdV species among age groups
The age range of patients from whom HAdV isolates were
obtained was 2 months to 56 years. Thirty-six of the 105
HAdV isolates were obtained from children under two
years of age (Table 1, Figure 3). Of those, HAdV-C (n =
27) was more common than HAdV-B (n = 8) or HAdV-E
(n = 1) (p < 0.01). Three (9%) samples had HAdV-B/HAdV-
C coinfections and 1 (3%) had a HAdV-C coinfection.
Forty-eight isolates were recovered from children ages 2
through 17 years. Of these, there was no statistical dif-
ference in serotypes (p = 0.12) or coinfections identified.
In the third age group, 18 years of age and older, 19 iso-
lates were recovered, including one HAdV-B/HAdV-C
coinfection, again with no significant differences (p =
0.81). Age is unknown for one of the HAdV-B/HAdV-C
coinfections. Across the entire patient population, HAdV-
B was significantly more common among ages 2 through
17 (p < 0.01) and HAdV-C was significantly more com-
mon in ages less than 2 (p < 0.01). Coinfections were sig-
nificantly more likely in patients under age 2 than in older
patients (p = 0.04).
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Geographic distribution of HAdV species
Clinical specimens were obtained at eight surveillance
sites distributed throughout 4 major regions in Egypt
(Table 1, Figure 1). In Alexandria, HAdV-C was relatively
more prevalent than HAdV-B (p < 0.01). The only HAdV-
E strain was also isolated from this location. Samples col-
lected in Upper Egypt were significantly more likely to be
HAdV-C (n = 23) than HAdV-B (n = 7) (p < 0.01). There
were no statistically significant differences in species pro-
portions in the Delta region (p = 0.32) or in Greater Cairo
(p = 0.54).
Distribution of species by year of isolation and season
Significantly more isolates, 59%, were recovered from
samples collected from March-June, which represents the
spring and beginning of summer when average tempera-
tures increase from 15°C in February to between 17°C and
27°C, than in the rest of the year (p < 0.01) (Table 2). Only
28% of isolates were recovered from samples during the
typical influenza virus season (September-February). From
the beginning of surveillance, none of the identified types
circulated continuously during the eight years of sam-
pling. HAdV-3 (HAdV-B) and HAdV-5 (HAdV-C) were
detected every year after first being identified in 2005
(Table 2). HAdV-2 appeared in 2006, and HAdV-7 in
2008, and both circulated through 2010. The other types
were identified sporadically throughout the surveillance
period. The only HAdV-E isolate was recovered in April
2009.
Discussion
In this retrospective study, we characterized HAdV iso-
lates derived from an ILI surveillance program con-
ducted as collaboration between the Egyptian Ministry
of Health and Population and NAMRU-3 between 2003
and 2010. This study builds on knowledge gleaned from
previous work conducted by Metzgar et al. that exam-
ined isolates in the NAMRU-3 collection from 1999 to
2002 [6].
Data from the current study indicate that HAdV con-
tinues to circulate among outpatients with ILI in Egypt
and that HAdV-B and HAdV-C appear to remain the
Table 1 Descriptive data, by year, region, age and sex, for HAdV infections by species and genotype (n = 105)
HAdV-B HAdV-C HAdV-E TOTAL
HAdV-3 HAdV-7 HAdV-11 Total HAdV-1 HAdV-2 HAdV-5 HAdV-6 Total HAdV-4 Total
n % n % n % n % n % n % n % n % n % n % n %
Year
2003 0 0% 0 0% 0 0% 0 0% 1 50% 0 0% 0 0% 1 50% 2 100% 0 0% 0 0% 2
2004 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0 0% 0
2005 2 40% 0 0% 2 40% 4 80% 0 0% 0 0% 1 20% 0 0% 1 20% 0 0% 0 0% 5
2006 3 38% 0 0% 0 0% 3 38% 2 25% 2 25% 1 13% 0 0% 5 63% 0 0% 0 0% 8
2007 2 20% 0 0% 1 10% 3 30% 3 30% 1 10% 3 30% 0 0% 7 70% 0 0% 0 0% 10
2008 3 30% 4 40% 1 10% 8 80% 0 0% 2 20% 0 0% 0 0% 2 20% 0 0% 0 0% 10
2009 9 29% 5 16% 1 3% 15 48% 6 19% 5 16%c 4 13% 0 0% 15 48% 1 3% 1 3% 31
2010 3 8% 5 13% 3 8% 11 28% 10 26% 10 26% 6 15% 2 5% 28 28 0 0% 0 0% 39
Region
Alexandria 8 33% 0 0% 0 0% 8 33% 7 29% 5 21% 2 8% 1 4% 15 63% 1 4% 1 4% 24
Delta 2 22% 3 33% 1 11% 6 67%c 3 33% 0 0% 0 0% 0 0% 3 33% 0 0% 0 0% 9
Greater Cairo 8 19% 8 19% 7 17% 23 55% 5 12% 6 14% 7 17% 1 2% 19 45% 0 0% 0 0% 42
Upper Egypt 4 13% 3 10% 0 0% 7 23% 7 23% 9 30% 6 20% 1 3% 23 77% 0 0% 0 0% 30
Age
< 2 years 3 8% 5 14% 0 0% 8 22% 8 22% 8 22% 10 28% 1 3% 27 75% 1 3% 1 3% 36
2-17 years 11 23% 9 19% 7 15% 27 56% 7 15% 9 19% 3 6% 2 4% 21 44% 0 0% 0 0% 48
≥ 18 years 7 37% 0 0% 1 5% 8 42% 6 32% 3 16% 2 11% 0 0% 11 58% 0 0% 0% 0% 19
Unknown 1 50% 0 0% 0 0% 1 50% 1 50% 0 0% 0 0% 0 0% 1 50% 0 0% 0 0% 2
Sex
Male 7 17% 8 19% 4 10% 19 45% 7 17% 9 21% 5 12% 2 5% 23 55% 0 0% 0 0% 42
Female 14 23% 6 10% 4 7% 24 39% 14 23% 11 18% 10 16% 1 2% 36 59% 1 2% 1 2% 61
Unknown 1 50% 0 0% 0 0% 1 50% 1 50% 0 0% 0 0% 0 0% 1 50% 0 0% 0 0% 2
TOTAL 22 21% 14 13% 8 8% 44 42% 22 21% 20 19% 15 14% 3 3% 60 57% 1 1% 1 1% 105
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most prevalent species within this patient population. In
contrast to the earlier results reported by Metzgar et al.,
HAdV-C was recovered in a higher prevalence than
HAdV-B [6]. Though not statistically significant (p = 0.11),
this relative prevalence is consistent with findings in
Malaysia [7], though differs from studies in the United
Kingdom [17] and Korea [31]. Unfortunately additional
data from elsewhere in the region are not available for
comparison. Differences in dominant HAdV species could
be due to factors such as variations in geographic location,
time period and sampling methodologies. Additionally,
studies also indicate that HAdV-C is the most prevalent
HAdV recovered from upper respiratory tract infec-
tions, in agreement with our findings from outpatients
Figure 3 Distribution of adenovirus positive isolates by age-group and species (n = 105) – HAdV-B (red), HAdV-C (blue),
HAdV-E (purple).
Figure 2 Distribution of adenovirus positive isolates (n = 105), by species – HAdV-B (red), HAdV-C (blue), HAdV-E (purple) – and type.
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with ILI [32,33], whereas HAdV-B1 serotypes (HAdV-3, -7)
are more prominent in lower respiratory tract infec-
tions [28,34-37]. Another possible explanation is that
we may have detected both active and latent infections
of HAdV-C through use of OP swabs [38], since labora-
tory methods used do not allow us to differentiate the
two [28,32,34,37,39].
Among the HAdV-B isolates recovered, significantly
more cases of HAdV-3 and HAdV-7, the primary HAdV-
B types in respiratory infections, were identified, both of
which have been associated with severe outbreaks and
are classified in subspecies HAdV-B1 [6]. Contrastingly,
infection with HAdV-11 (subspecies HAdV-B2) appears
rare, especially in respiratory infections [40]. HAdV-1
was the most common HAdV-C type identified, followed
by HAdV-2 and HAdV-5. Only two HAdV-6 isolates were
identified in our collection of HAdV isolates, and this type
was not detected in the previous study in Egypt [6]. Com-
parable proportions of HAdV-1, -2 and −5 were identified
by Garnett et al., though this distribution is unexpected
since HAdV-1 and −2 are more generally common in re-
spiratory infections than HAdV-5 [38]. The HAdV-E iso-
late was typed as HAdV-4, the sole human type in this
species, which is relatively rare in civilian populations,
though associated with viral conjunctivitis outbreaks in
Japan [41] and Australia [42]. It is more commonly associ-
ated with high rates of febrile respiratory illness in US
military recruits [6,43-45]. The single HAdV-4 isolate was
identified in April, which preceded the introduction of in-
fluenza A (H1N1) pdm09 into Egypt in June 2009 [46,47].
HAdV-B and HAdV-C infections were significantly as-
sociated with younger patients, which is expected given
that HAdV is the second most common viral respiratory
pathogen in children under 2 years of age [48]. HAdV-C
was strongly associated with age less than 2, which may
be related to the fact that this species is often endemic
in this age group [6] and that the presence of HAdV-C
in the tonsils peaks at age 4 [38]. Although HAdV-E is
typically associated with adult infection [32], the only
case observed in this study occurred in a child under
two years of age. Adenoviral coinfections were also more
frequent among patients under age 2 (p = 0.04). It should
be noted that this study might have under-estimated the
number of coinfections due to the testing algorithm that
was utilized. The initial isolation was performed in cell
lines routinely used in our laboratory for recovery of all
respiratory viruses. However, given the differences in
known cell surface receptors for HAdV types, we could
have biased our isolation of certain species and types,
and therefore also coinfections within a given sample.
The PCR protocol for HAdV-B typing could have also led
to under-estimation. Samples that were HAdV-B positive,
but negative for the HAdV-3/7/21 multiplex were tested
for the remainder of the HAdV-B types, HAdV-11, -14,
-16, and −35, but samples that were positive for HAdV-3/
7/21 were not tested for the additional types, and we could
have missed samples that contained a coinfection of mul-
tiple types of HAdV-B.
HAdV occurs throughout the year, with outbreaks that
are common from late winter through early summer
months [5]. Although denominator data to support exam-
ination of seasonality are not available, it is notable that 58
out of the 105isolates identified in this study were isolated
over a four-month period from March through June
(Table 2), suggesting that the peak of circulation occurred
during this time frame. This timing is also consistent with
the expected circulation of HAdV-C [32], which was the
most frequent species observed in this study. Larger sam-
ple sizes and broader surveillance data on ILI are required
to fully delineate the seasonal distribution of HAdV.
Human adenovirus infections are a significant cause of a
wide range of disease, including respiratory infections
[28,33,49], and this study has established that HAdV con-
tinues to circulate in Egypt. The dominant species in cir-
culation appears to be HAdV-C, though HAdV-B and
HAdV-E have also been identified in patients with ILI. The
circulation of HAdV-3, HAdV-5 and HAdV-7 is of note as
these types are recognized causes of more severe acute re-
spiratory infection [50]. Scientists and medical personnel
concerned with the etiology of acute respiratory infections
Table 2 Distribution of HAdV infections by month and year (n = 105)
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2003 0 0 0 2 0 0 0 0 0 0 0 0
2004 0 0 0 0 0 0 0 0 0 0 0 0
2005 0 0 0 0 0 1 0 2 0 2 0 0
2006 0 0 1 0 0 0 1 0 1 0 3 2
2007 1 2 1 0 0 6 0 0 0 0 0 0
2008 0 0 0 0 2 0 1 3 0 2 1 1
2009 1 2 8 5 3 4 1 0 0 3 2 2
2010 0 4 5 7 9 8 4 2 0 0 0 0
TOTAL 2 8 15 14 14 19 7 7 1 7 6 5
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in Egypt should consider HAdV as a potential cause, given
this evidence of infection among patients with ILI.
Conclusions
We identified three species, HAdV-B, -C and -E, among
patients with ILI over the course of 7 years in Egypt, with
at least eight diverse types circulating. Continued surveil-
lance and characterization is necessary to understand the
contribution of HAdV and its genotypes to acute respira-
tory disease in the region.
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